What we welcome
Three kinds of messages are useful to receive. First, factual corrections — if a study is misquoted, a dose value is wrong, or a citation points to the wrong paper, we want to know and we will fix the page. Please include the URL of the affected page and the citation number you are commenting on.
Second, source suggestions — if a relevant peer-reviewed paper, FDA document, or registered clinical trial is missing from the references list, send the DOI or PubMed ID and a one-line note about what it adds. The literature on bremelanotide is small enough that we try to keep the references page comprehensive within the scope of what the site covers.
Third, citation and reading-list requests from clinicians, journalists, researchers, and patient-education writers who are working on bremelanotide and would like the references in a different format (BibTeX, RIS, EndNote, plain-text APA) — we are happy to share.
What we cannot help with
We cannot provide medical advice. We cannot evaluate whether bremelanotide is appropriate for a specific person, recommend a dose, comment on someone's symptoms or test results, suggest off-label use, or interpret a prescription. Those questions need a licensed clinician who has access to the relevant medical history; nothing on this site is a substitute for that conversation.
We also do not refer readers to any pharmacy, telehealth service, compounding facility, or supplier of bremelanotide or PT-141. We have no commercial relationship with any vendor or manufacturer, and we do not publish a list of recommended sources. Inquiries asking us to recommend a place to purchase the compound will not receive a reply.
How to reach the editorial team
The contact form below sends an email to the editorial inbox. Please include enough specifics that we can act on the message — for corrections, the page URL and citation number; for source suggestions, the DOI or PubMed link; for citation requests, the format you would like. We try to respond to actionable editorial messages within a week or two. Unsolicited press releases, marketing inquiries, vendor pitches, and requests for paid placement are not read.
Editorial contact form
Unsolicited press releases, marketing inquiries, vendor pitches, and requests for paid placement are not read.